Evidence map›Paper›PMID 12729461›Full record

ArticleThe Biochemical journal2003

Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.

Bysani Chandrasekar, Srinivas Mummidi, Rao P Perla, Sailaja Bysani, Nickolai O Dulin, Feng Liu, Peter C Melby

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 156 citations in OpenAlex.

  1. Review
  2. CX3CR1Cancer science · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Fractalkine/CX3CL1 in Neoplastic Processes.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Polymorphisms within theInfection and immunity · 2020
    Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bysani ChandrasekarDepartment of Medicine, University of Texas Health Science Center, San Antonio, TX 78229, USA. chandraseka@uthscsa.edu
Srinivas Mummidi
Rao P Perla
Sailaja Bysani
Nickolai O Dulin
Feng Liu
Peter C Melby
The University of Texas Health Science Center at San Antonio · USUniversity of Chicago · US

Funding

Chemokines, nitric oxide, and myocardial depressionR01HL068020 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI CHANDRASEKAR, BYSANI · 2002 to 2005
$935k
NHLBI NIH HHS HL68020
6 · The paper itself

Abstract

Fractalkine (also known as CX3CL1), a CX3C chemokine, activates and attracts monocytes/macrophages to the site of injury/inflammation. It binds to CX3C receptor 1 (CX3CR1), a pertussis toxin-sensitive G-protein-coupled receptor. In smooth muscle cells (SMCs), fractalkine is induced by proinflammatory cytokines [tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma)], which may mediate monocyte adhesion to SMCs. However, the mechanisms underlying its induction are unknown. In addition, it is unlear whether SMCs express CX3CR1. TNF-alpha activated nuclear factor kappaB (NF-kappaB) and induced fractalkine and CX3CR1 expression in a time-dependent manner in rat aortic SMCs. Transient transfections with dominant-negative (dn) inhibitory kappaB (IkappaB)-alpha, dnIkappaB-beta, dnIkappaB kinase (IKK)-gamma, kinase-dead (kd) NF-kappaB-inducing kinase (NIK) and kdIKK-beta, or pretreatment with wortmannin, Akt inhibitor, pyrrolidinecarbodithioc acid ammonium salt ('PDTC') or MG-132, significantly attenuated TNF-alpha-induced fractalkine and CX3CR1 expression. Furthermore, expression of dn TNF-alpha-receptor-associated factor 2 (TRAF2), but not dnTRAF6, inhibited TNF-alpha signal transduction. Pretreatment with pertussis toxin or neutralizing anti-CX3CR1 antibodies attenuated TNF-alpha-induced fractalkine expression, indicating that fractalkine autoregulation plays a role in TNF-alpha-induced sustained fractalkine expression. Fractalkine induced its own expression, via pertussis toxin-sensitive G-proteins, phosphoinositide 3-kinase (PI 3-kinase), phosphoinositide-dependent kinase 1 (PDK1), Akt, NIK, IKK and NF-kappaB activation, and induced SMC cell-cell adhesion and cellular proliferation. Taken together, our results demonstrate that TNF-alpha induces the expression of fractalkine and CX3CR1 in rat aortic SMCs and that this induction is mediated by NF-kappaB activation. We also show that fractalkine induces its own expression, which is mediated by the PI 3-kinase/PDK1/Akt/NIK/IKK/NF-kappaB signalling pathway. More importantly, fractalkine increased cell-cell adhesion and aortic SMC proliferation, indicating a role in initiation and progression of atherosclerotic vascular disease.

Indexed as

Protein Serine-Threonine KinasesAndrostadienesAnimalsAntineoplastic AgentsAortaAutocrine CommunicationCell DivisionCells, CulturedChemokine CX3CL1Chemokines, CX3CCX3C Chemokine Receptor 1Electrophoretic Mobility Shift AssayEnzyme InhibitorsGTP-Binding ProteinsI-kappa B ProteinsLuciferasesAkt1 protein, ratAndrostadienesAntineoplastic AgentsChemokine CX3CL1Chemokines, CX3CCX3C Chemokine Receptor 1Cx3cl1 protein, ratEnzyme InhibitorsGTP-Binding ProteinsI-kappa B ProteinsLuciferasesMembrane ProteinsNF-kappa BPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProlineprolinedithiocarbamateProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktReceptors, CytokineReceptors, HIVRNA, MessengerThiocarbamatesTNF Receptor-Associated Factor 2TNF Receptor-Associated Factor 6Tumor Necrosis Factor-alphaWortmannin

Identifiers

PMID12729461
PMCPMC1223517
OpenAlexW1990078228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.